Abbott clinical biochemical second-generation alkaline phosphatase assay group
Taiwan·Risk Class 2·ABBOTT IRELAND DIAGNOSTICS DIVISION·Registered Sep 30, 2022 – Sep 30, 2027Active- Analysis ID
- ec162c9afcee9f24aa0fc56980018956
- Customs Code
- DHA05603585603
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Manufacturer Country
- Ireland
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
- Intended Use
- This product is used on the ARCHECT c system to quantify alkaline phosphatase in human serum or plasma.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1050 Alkaline phosphatase or isoenzyme testing system
- Import Information
- QMS/QSD;; 輸入
- Registration Date
- Sep 30, 2022
- Expiry Date
- Sep 30, 2027
Access comprehensive regulatory information for Abbott clinical biochemical second-generation alkaline phosphatase assay group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ec162c9afcee9f24aa0fc56980018956 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.